A potential U.S. launch of this Chinese biotech's new lung cancer drug - which bested Merck's blockbuster Keytruda - is a key ...

Markets initially soared on Trump’s U-turn, but Wall Street banks and investors warned that even with the adjustments, America’s tariff rate would remain at the highest level in more than a century — ...

Markets initially soared on Trump’s U-turn, but Wall Street banks and investors warned that even with the adjustments, America’s tariff rate would remain at the highest level in more than a century — ...

Markets slump. Wallets shrink. But for a rare group of strategic thinkers, that's the moment to lean in, not back away. While most people panic-sell, the experienced launch fresh ventures and buy what ...

Already on Thursday, stocks were giving back a chunk of Wednesday's historic gain. Goldman Sachs says the tariff pause likely ...

We recently published a list of Jim Cramer Says Tariff Pain Isn’t Over Yet And Reviews These 9 Stocks. In this article, we ...

Goldman Sachs faces a challenging outlook with expected lower economic growth, impacting IPOs. Check out why I downgrade GS ...

Economists at Goldman Sachs walked back a forecast calling for a recession hours after President Donald Trump announced a ...

Last time I wrote about Goldman Sachs, my rating was a sell. Check out why I maintain my sell rating on GS stock.

Investor belief in US superiority drove Wall Street to sky-high valuations, but the president’s trade war is now eroding this ...